摘要
目的:探讨类风湿关节炎采取规范化药物治疗以及临床效果。方法:选择我院2019年7月-2021年1月期间接收的90例类风湿关节炎患者为例,以问卷方法调查患者的治疗效果,主要内容包含患者的基本资料、就诊时间、确诊时间、诊疗科室,随诊时间距离及其患者疾病使用抗风湿药物的改善状况。结果:此病使用不规范治疗药物,患者使用抗风湿类药物最多的就是甲氨蝶呤(59%),其次为氟米特(29%)、柳氮磺吡啶(6%)、羟氯喹(6%)。结论:50%患者在县基层医院采用抗风湿类药的治疗效果不理想。类风湿关节炎规范治疗需要从早诊治,完善联合用药,规范治疗,定期追踪治疗效果方面加以规范。
Objective: To investigate the standardized drug treatment of rheumatoid arthritis and clinical results. Methods: A total of 90 patients with rheumatoid arthritis admitted to our hospital from July 2019 to January 2019 were selected. The therapeutic effect was investigated by questionnaire, including the basic data of patients, the time of seeing a doctor, the time of diagnosis and treatment, time of follow-up and the improvement of using anti-rheumatic drugs. Results: The most common anti-rheumatic drugs were methotrexate(59%), followed by flumette(29%), sulfasalazine(6%) and hydroxychloroquine(6%). Conclusion: The therapeutic effect of anti-rheumatism drugs is not satisfactory for 50% patients in county-level hospitals. The standardized treatment of rheumatoid arthritis needs early diagnosis and treatment, perfect combination of drugs, standardized treatment and regular follow-up.
作者
张图门
ZHANG Tu-men(Affiliated Hospital of Inner Mongolia University for the Nationalities)
出处
《中国标准化》
2021年第18期173-175,共3页
China Standardization
关键词
类风湿关节炎
药物治疗
规范化
临床实践
rheumatoid arthritis
drug therapy
standardization
clinical practice
